Geneva Capital Management LLC Purchases Shares of 3,069 Danaher Corporation $DHR

Geneva Capital Management LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 3,069 shares of the conglomerate’s stock, valued at approximately $585,000.

Other hedge funds have also made changes to their positions in the company. Northwestern Mutual Wealth Management Co. raised its holdings in Danaher by 303.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after purchasing an additional 186,584 shares in the last quarter. Legal & General Group Plc lifted its position in shares of Danaher by 1.0% during the 4th quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock worth $1,029,061,000 after buying an additional 43,169 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Danaher by 51.5% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 271,734 shares of the conglomerate’s stock valued at $62,205,000 after buying an additional 92,323 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Danaher by 41.8% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 168,163 shares of the conglomerate’s stock valued at $38,496,000 after buying an additional 49,559 shares during the last quarter. Finally, Advisors Capital Management LLC grew its position in shares of Danaher by 14.0% in the 4th quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock valued at $12,555,000 after buying an additional 6,720 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 0.7%

Shares of Danaher stock opened at $202.51 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a market capitalization of $142.37 billion, a P/E ratio of 35.97, a PEG ratio of 2.52 and a beta of 0.78. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company’s fifty day moving average is $193.14 and its two-hundred day moving average is $193.21.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same period in the prior year, the company earned $0.77 earnings per share. The business’s revenue was up 5.5% compared to the same quarter last year. Analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on DHR. Evercore reiterated an “outperform” rating and set a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. UBS Group dropped their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Guggenheim cut their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Stifel Nicolaus reduced their target price on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average price target of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.